Generation of cytotoxic T-cell responses with synthetic melanoma-associated peptidesin vivo: Implications for tumor vaccines with melanoma-associated antigens

E. Jaeger, Helga Bernhard, Pedro Romero, +6

International Journal of Cancer

Perioperative chemotherapy with docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) versus epirubicin, cisplatin, and fluorouracil or capecitabine (ECF/ECX) for resectable gastric or gastroesophageal junction (GEJ) adenocarcinoma (FLOT4-AIO): A multicenter, randomized phase 3 trial.

Salah‐Eddin Al‐Batran, Nils Homann, Harald Schmalenberg, +16

Journal of Clinical Oncology

Surgical OncologyEsophageal CancerCancer ManagementGastroenterologyPharmacotherapy +14

A randomized, double-blind, placebo-controlled, phase III study in patients (Pts) with metastatic adenocarcinoma of the colon or rectum receiving first-line chemotherapy with oxaliplatin/5-fluorouracil/leucovorin and PTK787/ZK 222584 or placebo (CONFIRM-1)

J. Randolph Hecht, Tanja Trarbach, E. Jaeger, +7

Journal of Clinical Oncology

Tyrosine KinasePathologySurgeryOncologyGastrointestinal Oncology +15

Phase II Trial of Biweekly Infusional Fluorouracil, Folinic Acid, and Oxaliplatin in Patients With Advanced Gastric Cancer

Salah‐Eddin Al‐Batran, Akin Atmaca, Susanna Hegewisch‐Becker, +8

Journal of Clinical Oncology

Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?

Elena Neumann, Arne Engelsberg, Jean Decker, +4

PubMed

T-regulatory CellImmunologyTumor-associated Antigens Rage-1PathologyImmunoediting +17

A phase IIa study of PEGylated glutaminase (PEG-PGA) plus 6-diazo-5-oxo-L-norleucine (DON) in patients with advanced refractory solid tumors

Claudius Mueller, S. Al-Batran, E. Jaeger, +4

Journal of Clinical Oncology

Phase Iia StudyPharmacotherapyGliomaPre-clinical PharmacologyMetronomic Therapy +15

Docetaxel, oxaliplatin, and fluorouracil/leucovorin (FLOT) for resectable esophagogastric cancer: Updated results from multicenter, randomized phase 3 FLOT4-AIO trial (German Gastric Group at AIO)

S-E. Al-Batran, Claudia Pauligk, Nils Homann, +17

Annals of Oncology

Surgical OncologyEsophagusResectable Esophagogastric CancerGastrointestinal OncologyFlot4-aio Trial +9

Induction of immunogenicity of a human renal-cell carcinoma cell line byTAP1-gene transfer

Michael Kallfelz, Dirk Jung, Christine Hilmes, +4

International Journal of Cancer

Expression and function of the peptide transporters in escape variants of human renal cell carcinomas.

Barbara Seliger, A Höhne, Da Jin Sol Jung, +7

PubMed

Strong Immunogenic Potential of a B7 Retroviral Expression Vector: Generation of HLA-B7-Restricted CTL Response Against Selectable Marker Genes

Dirk Jung, E. Jaeger, S Cayeux, +7

Human Gene Therapy